Medtronic Inc.’s (NYSE:MDT) got the go-ahead to pursue trials of its Symplicity catheter system for treating hypertension via renal denervation.
The system includes a catheter inserted into the renal artery near each kidney via the femoral artery in the upper thigh. A generator on the tip of the catheter delivers lower-power radio-frequency energy to "deactivate" the sympathetic nerves, lowering blood pressure.
Ben Franklin Technology Partners of Northeastern Pennsylvania invested $60,000 in two Lehigh Valley, Pa.-based medical companies.
The Bethlehem, Pa.-based, state-funded organization invested $50,000 in HealthOneMed Inc. and $10,000 in B. Braun Medical Inc.
Allentown, Pa.-based HealthOneMed plans to employ the funding to complete a marketing plan for its first product, Dispense-A-Pill, a patented device that dispenses pharmaceutical tablets on a pre-programmed schedule.